Drugs / BI 671800 HEA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02222233 | Jan → Mar 2010 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 671800 HEA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02222233 ↗ |
| Route | Oral | “Administered Orally as a Delayed Release (Enteric Coated) Tablet” NCT02222233 ↗ |